Literature DB >> 14699601

Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes.

Ulrich Huth1, Ansgar Wieschollek, Yuval Garini, Rolf Schubert, Regine Peschka-Süss.   

Abstract

BACKGROUND: To improve the efficiency of liposomal drug targeting systems, it is necessary to understand the mechanism of liposome uptake by the cell and to follow the intracellular fate of internalized liposomes and their contents.
METHODS: We applied multiple-color fluorescence imaging spectroscopy, using a combination of five fluorescent dyes with a significant spectral overlap. pH-sensitive liposomes were labeled with the hydrophilic dye fluorescein isothiocyanate-dextran (FITC-dextran) or the lipophilic membrane marker rhodamine-B-phosphoethanolamine (Rh-PE) and incubated with COS-7 cells. Further, the cells were stained with specific markers: the cell membrane was fluorescently labeled with Vybrant DiO, lysosomes were stained with LysoTracker Red, and 4',6 diamidino-2-phenylindole dihydrochloride was used for counterstaining the nucleus.
RESULTS: All five dyes were used simultaneously and were spectrally distinguished by the system. FITC-dextran-labeled liposomes showed a distribution pattern different from identically composed liposomes labeled with Rh-PE: the highly lipophilic Rh-PE was colocalized with the lysosomotropic dye LysoTracker Red, whereas liposomal FITC-dextran was not accompanied by LysoTracker Red in all cases.
CONCLUSIONS: (a) Spectral (bio-) imaging is a powerful method for studying the intracellular fate of liposomal compounds. (b) We assume that the liposome membrane marker Rh-PE influences the uptake of particles due to its surface-modifying properties. We propose that this head-group-labeled phospholipid acts as a ligand for cellular receptors and triggers receptor-mediated (clathrin-dependent) endocytosis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699601     DOI: 10.1002/cyto.a.10105

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  7 in total

1.  Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B.

Authors:  Alexander Koshkaryev; Ritesh Thekkedath; Cinzia Pagano; Igor Meerovich; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2011-01-29       Impact factor: 5.121

2.  Microtubule-dependent movement of late endocytic vesicles in vitro: requirements for Dynein and Kinesin.

Authors:  Eustratios Bananis; Sangeeta Nath; Kristie Gordon; Peter Satir; Richard J Stockert; John W Murray; Allan W Wolkoff
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

3.  The role of the C-terminus for functional heteromerization of the plant channel KDC1.

Authors:  Alessia Naso; Ingo Dreyer; Laura Pedemonte; Ilaria Testa; Judith Lucia Gomez-Porras; Cesare Usai; Bernd Mueller-Rueber; Alberto Diaspro; Franco Gambale; Cristiana Picco
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

4.  Screening and optimization of ligand conjugates for lysosomal targeting.

Authors:  Igor Meerovich; Alexander Koshkaryev; Ritesh Thekkedath; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2011-10-06       Impact factor: 4.774

Review 5.  Targeted nanoparticles in mitochondrial medicine.

Authors:  Rakesh K Pathak; Nagesh Kolishetti; Shanta Dhar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-27

6.  Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro.

Authors:  Ritesh Thekkedath; Alexander Koshkaryev; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2012-12-02       Impact factor: 5.307

7.  Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells.

Authors:  M A E M van der Aa; U S Huth; S Y Häfele; R Schubert; R S Oosting; E Mastrobattista; W E Hennink; R Peschka-Süss; G A Koning; D J A Crommelin
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.